| Financial Year |
March 31 2023 |
| Monetary Funds |
9,204,724,635.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
745,233,823.43 |
| Accounts Receivable |
10,511,437,828.05 |
| Advances to Suppliers |
961,508,371.90 |
| Other Receivables |
418,683,766.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,499,150.00 |
| Inventories |
6,287,111,018.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
30,347,365.63 |
| Other Current Assets |
284,952,716.55 |
| Total Current Assets |
31,759,994,507.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
43,967,242.54 |
| Long-term Equity Investment |
813,904,394.59 |
| Investment Properties |
126,969,976.53 |
| Fixed Assetes |
5,338,632,424.41 |
| Under-construction Projects |
1,448,940,349.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
3,104,983.26 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,775,250,346.22 |
| R&D expenses |
3,666,752.87 |
| Goodwill |
3,471,142.92 |
| Long-Term Deferred and Prepaid Expenses |
104,653,207.78 |
| Deferred Income Tax Assets |
791,217,298.90 |
| Other Non-Current Assets |
39,144,755.76 |
| Sub-Total of Non-Current Assets |
13,597,036,988.60 |
| Total Assets |
45,357,031,495.90 |
| Short-Term Loans |
157,495,803.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
310,728,521.16 |
| Accounts Payable |
9,871,387,004.09 |
| Accounts Received In Advance |
20,855,704.60 |
| Employee Compensation Payable |
1,287,633,518.80 |
| Taxes Payable |
316,247,093.74 |
| Interest Payable |
-- |
| Dividend Payable |
62,400.00 |
| Other payables |
1,132,963,489.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
98,602,546.42 |
| Other Current Liabilities |
544,099,740.76 |
| Sub-Total of Current Liabilities |
17,148,562,839.33 |
| Long-term Loans |
169,580,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
48,385,906.01 |
| Special Payable |
-- |
| Estimatied Liabilities |
137,478,441.88 |
| Deferred Income Tax Liabilities |
25,505,379.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,474,378,566.33 |
| Total Liabilities |
19,622,941,405.66 |
| Paid-In Capital(Or Share Stock) |
4,138,588,892.00 |
| Capital Surplus |
1,749,624,814.14 |
| Surplus Reserve |
719,298,256.98 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
14,067,236,204.62 |
| Minority Stockholder's Interest |
4,717,335,055.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
21,016,755,035.03 |
| Owner's Equity（Stockholder's Equity） |
25,734,090,090.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
45,357,031,495.90 |
